Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad M Johannes

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
BMC Veterinary Research|August 12, 2021
Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinomaMargaret L Musser, Chad M Johannes
The Veterinary Clinics of North America. Small Animal Practice|June 10, 2019
Anorexia and the Cancer PatientChad M Johannes, Margaret L Musser
The Veterinary Clinics of North America. Small Animal Practice|January 6, 2024
New Therapies in Veterinary OncologyChristine Mullin, Craig A Clifford, Chad M Johannes
Frontiers in Veterinary Science|October 11, 2021
A Retrospective Evaluation of Chemotherapy Overdoses in Dogs and CatsMargaret L Musser, Kaitlin M Curran, Brian K Flesner, et al.
BMC Veterinary Research|September 5, 2018
Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017)Margaret L Musser, Kathryn L Taikowski, Chad M Johannes, et al.
Journal of Veterinary Internal Medicine|December 22, 2020
Recurrence-free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglatePamela D Jones, Justine E Campbell, Graham Brown, et al.
BMC Veterinary Research|December 23, 2019
Vaccine strain Listeria monocytogenes abscess in a dog: a case reportMargaret L Musser, Erika P Berger, Cameron Parsons, et al.
Plos One|December 22, 2022
Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcomaMargaret L Musser, Giovanna M Coto, Yuan Lingnan, et al.
Veterinary and Comparative Oncology|July 12, 2021
Prostaglandin EP4 receptor mRNA expression in canine lymphomaMargaret L Musser, Austin K Viall, Rachel L Phillips, et al.
Journal of Veterinary Internal Medicine|October 17, 2024
Response to tigilanol tiglate in dogs with mast cell tumorsMargaret L Musser, Pamela D Jones, Teresa L Goodson, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
BMC Veterinary Research|August 12, 2021
Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinomaMargaret L Musser, Chad M Johannes
The Veterinary Clinics of North America. Small Animal Practice|June 10, 2019
Anorexia and the Cancer PatientChad M Johannes, Margaret L Musser
The Veterinary Clinics of North America. Small Animal Practice|January 6, 2024
New Therapies in Veterinary OncologyChristine Mullin, Craig A Clifford, Chad M Johannes
Frontiers in Veterinary Science|October 11, 2021
A Retrospective Evaluation of Chemotherapy Overdoses in Dogs and CatsMargaret L Musser, Kaitlin M Curran, Brian K Flesner, et al.
BMC Veterinary Research|September 5, 2018
Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017)Margaret L Musser, Kathryn L Taikowski, Chad M Johannes, et al.
Journal of Veterinary Internal Medicine|December 22, 2020
Recurrence-free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglatePamela D Jones, Justine E Campbell, Graham Brown, et al.
BMC Veterinary Research|December 23, 2019
Vaccine strain Listeria monocytogenes abscess in a dog: a case reportMargaret L Musser, Erika P Berger, Cameron Parsons, et al.
Plos One|December 22, 2022
Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcomaMargaret L Musser, Giovanna M Coto, Yuan Lingnan, et al.
Veterinary and Comparative Oncology|July 12, 2021
Prostaglandin EP4 receptor mRNA expression in canine lymphomaMargaret L Musser, Austin K Viall, Rachel L Phillips, et al.
Journal of Veterinary Internal Medicine|October 17, 2024
Response to tigilanol tiglate in dogs with mast cell tumorsMargaret L Musser, Pamela D Jones, Teresa L Goodson, et al.
Pageof 4